There are three major subtypes of amyloidosis: primary amyloidosis, secondary amyloidosis, and hereditary amyloidosis (Khan & Falk, 2001; Nakata & Shimamoto, 2003; Smith, 2003). Primary ...

Amvuttra (vutrisiran) is a prescription drug that’s used to treat nerve damage and weakened heart muscles related to a condition called ATTR amyloidosis. Amvuttra is given as an injection under ...

Lowering levels of circulating transthyretin with vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) decreased their risk for mortality and cardiovascular events ...

Medical testing laboratory Dr. Lal PathLabs said on Tuesday that it has become south Asia’s first diagnostic chain to offer an advance test for amyloidosis, a rare but critical disease caused by ...

Dr Lal PathLabs has introduced Amyloid Typing by Laser Capture Microdissection & Mass Spectrometry – a test for accurately identifying different types of Amyloid proteins. With this launch, DLPL ...

Pohang University of Science and Technology (POSTECH), 77 Cheongam-Ro, Nam-Gu, Pohang, Gyeongbuk 37673, Republic of Korea Amyloid Solution Inc., 58 Pangyo-ro 255 beon-gil, Bundang-gu, Seongnam-si, ...

The following is a summary of “Immunoglobulin heavy/light chain assay in the diagnosis, monitoring and follow-up of renal AL amyloidosis patients at different disease stages,” published in the April ...

Alzheon’s con­tro­ver­sial, decade-long bet that a failed Alzheimer’s drug could of­fer big­ger ben­e­fits to a sub­set of pa­tients at the high­est risk for the dis­ease … ...

Credit: Billion Photos / Shutterstock. Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related to Alzheimer’s disease in ...

Nonspecific symptoms and other diagnostic challenges lead to underdiagnosis of cardiac amyloidosis (CA). Artificial intelligence (AI) could help address these challenges, but a summary of the ...